Table 1.
Comparison of hematological findings in the treatment group compared to the placebo group at baseline and week 12 post-treatment
| Variables | Treatment | Placebo | P value |
|---|---|---|---|
| Mean ± SEM | Mean ± SEM | ||
| Fe(µg/d1)baseline | 71.90 ± 5.15 | 75.921 ± 6.91 | 0.63 |
| Fe(µg/d1)Post-T | 83.45 ± 4.56 | 71.07 ± 7.84 | 0.15 |
| K(mEq/L)baseline | 3.96 ± 0.09 | 4.32 ± 0.08 | 0.011 |
| K(mEq/L)Post-T | 4.15 ± 0.05 | 4.30 ± 0.16 | 0.37 |
| Ca(mg/d1)baseline | 9.14 ± 0.12 | 9.65 ± 0.13 | 0.010 |
| Ca(mg/d1)Post-T | 9.67 ± 0.10 | 8.97 ± 0.17 | 0.001 |
| Mg(mg/d1)baseline | 2.05 ± 0.03 | 2.141 ± 0.3 | 0.08 |
| Mg(mg/d1)Post-T | 2.15 ± 0.02 | 2.07 ± 0.04 | 0.07 |
| P(mg/d1)baseline | 3.35 ± 0.16 | 3.82 ± 0.13 | 0.05 |
| P(mg/d1)Post-T | 3.83 ± 0.12 | 3.53 ± 0.08 | 0.08 |
| Zn(µg/d1)baseline | 91.90 ± 3.80 | 92.64 ± 4.02 | 0.89 |
| Zn(pg/d1)Post-T | 101.86 ± 3.17 | 87.42 ± 4.33 | 0.012 |
| Na(mEq/L)baseline | 138.77 ± 0.96 | 141.35 ± 1.29 | 0.12 |
| Na(mEq/L)Post-T | 140.951 ± 0.74 | 138.78 ± 1.29 | 0.12 |
| Cu(µg/d1)baseline | 121.50 ± 10.26 | 124.21 ± 10.97 | 0.86 |
| Cu(µg/d1)Post-T | 110.13 ± 7.26 | 109.21 ± 10.61 | 0.94 |
Post-T post-treatment; SEM standard error of mean